Papers

2

Total Citations

18

H-Index

2

About

Melissa Bradbury is a leading figure in gynecologic oncology, with a focused expertise in minimally invasive surgical techniques for complex pelvic and abdominal cancers. Her research centers on advancing robotic-assisted procedures to improve patient outcomes, particularly in the management of advanced-stage disease. Bradbury’s most impactful work, a post hoc analysis of the STELLA-2 randomized trial, demonstrated that robot-assisted extraperitoneal para-aortic lymphadenectomy is associated with significantly fewer surgical complications compared to traditional approaches, a finding that has informed best practices in staging procedures. This study, with 15 citations, underscores her commitment to evidence-based surgical innovation. She has also contributed to refining techniques for fertility-preserving surgery, such as the development of retrocervical tunneling for accurate placement of robotic-assisted transabdominal cerclage. Her work bridges the gap between technical precision and clinical safety, earning her recognition as a thought leader in robotic gynecologic surgery. Bradbury’s contributions continue to shape how surgeons approach high-risk oncologic cases, reducing morbidity while maintaining oncologic efficacy.

Research Focus

Key Achievements

2
H-Index
2
Papers
18
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Extraperitoneal Para-aortic Lymphadenectomy Is Associated with Fewer Surgical Complications: A Post Hoc Analysis of the STELLA-2 Randomized Trial
15 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago